165 related articles for article (PubMed ID: 31952435)
1. In silico Evaluation of PLAC1-fliC As a Chimeric Vaccine against Breast Cancer.
Taheri-Anganeh M; Amiri A; Movahedpour A; Khatami SH; Ghasemi Y; Savardashtaki A; Mostafavi-Pour Z
Iran Biomed J; 2020 May; 24(3):173-82. PubMed ID: 31952435
[TBL] [Abstract][Full Text] [Related]
2. In Silico Design and Evaluation of PRAME+FliCΔD2D3 as a New Breast Cancer Vaccine Candidate.
Taheri-Anganeh M; Savardashtaki A; Vafadar A; Movahedpour A; Shabaninejad Z; Maleksabet A; Amiri A; Ghasemi Y; Irajie C
Iran J Med Sci; 2021 Jan; 46(1):52-60. PubMed ID: 33487792
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel HLA-A2-restricted cytotoxic T lymphocyte epitope from cancer-testis antigen PLAC1 in breast cancer.
Liu W; Zhai M; Wu Z; Qi Y; Wu Y; Dai C; Sun M; Li L; Gao Y
Amino Acids; 2012 Jun; 42(6):2257-65. PubMed ID: 21710262
[TBL] [Abstract][Full Text] [Related]
4. A novel multi-epitope peptide vaccine against cancer: an in silico approach.
Nezafat N; Ghasemi Y; Javadi G; Khoshnoud MJ; Omidinia E
J Theor Biol; 2014 May; 349():121-34. PubMed ID: 24512916
[TBL] [Abstract][Full Text] [Related]
5. In silico design of discontinuous peptides representative of B and T-cell epitopes from HER2-ECD as potential novel cancer peptide vaccines.
Manijeh M; Mehrnaz K; Violaine M; Hassan M; Abbas J; Mohammad R
Asian Pac J Cancer Prev; 2013; 14(10):5973-81. PubMed ID: 24289611
[TBL] [Abstract][Full Text] [Related]
6. Identification of two new HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from colorectal carcinoma-associated antigen PLAC1/CP1.
Liu F; Zhang H; Shen D; Wang S; Ye Y; Chen H; Pang X; Song Q; He P
J Gastroenterol; 2014 Mar; 49(3):419-26. PubMed ID: 23604623
[TBL] [Abstract][Full Text] [Related]
7. Immunoinformatics analysis of Brucella melitensis to approach a suitable vaccine against brucellosis.
Hashemzadeh P; Nezhad SA; Khoshkhabar H
J Genet Eng Biotechnol; 2023 Nov; 21(1):152. PubMed ID: 38019359
[TBL] [Abstract][Full Text] [Related]
8. Harnessing Bioinformatics for Designing a Novel Multiepitope Peptide Vaccine Against Breast Cancer.
Mahmoodi S; Nezafat N; Barzegar A; Negahdaripour M; Nikanfar AR; Zarghami N; Ghasemi Y
Curr Pharm Biotechnol; 2016; 17(12):1100-1114. PubMed ID: 27633889
[TBL] [Abstract][Full Text] [Related]
9. In silico design of a vaccine candidate based on autotransporters and HSP against the causal agent of shigellosis, Shigella flexneri.
León Y; Zapata L; Salas-Burgos A; Oñate A
Mol Immunol; 2020 May; 121():47-58. PubMed ID: 32163758
[TBL] [Abstract][Full Text] [Related]
10. In Silico Approach in Designing a Novel Multi-Epitope Vaccine Candidate against Non-Small Cell Lung Cancer with Overexpressed G Protein-Coupled Receptor 56.
Herrera LRM
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2297-2306. PubMed ID: 32856858
[TBL] [Abstract][Full Text] [Related]
11. In silico proteomic characterization of human epidermal growth factor receptor 2 (HER-2) for the mapping of high affinity antigenic determinants against breast cancer.
Baloria U; Akhoon BA; Gupta SK; Sharma S; Verma V
Amino Acids; 2012 Apr; 42(4):1349-60. PubMed ID: 21229277
[TBL] [Abstract][Full Text] [Related]
12. Computational screening and characterization of putative vaccine candidates of Plasmodium vivax.
Nanda Kumar Y; Jeyakodi G; Gunasekaran K; Jambulingam P
J Biomol Struct Dyn; 2016 Aug; 34(8):1736-50. PubMed ID: 26338678
[TBL] [Abstract][Full Text] [Related]
13. In silico analyses of heat shock protein 60 and calreticulin to designing a novel vaccine shifting immune response toward T helper 2 in atherosclerosis.
Karkhah A; Saadi M; Nouri HR
Comput Biol Chem; 2017 Apr; 67():244-254. PubMed ID: 28189968
[TBL] [Abstract][Full Text] [Related]
14. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Mortier MC; Jongert E; Mettens P; Ruelle JL
BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
[TBL] [Abstract][Full Text] [Related]
15. PLAC1 immunization does not induce infertility in mice.
Liso A; Massenzio F; Stracci F
Immunotherapy; 2017 May; 9(6):481-486. PubMed ID: 28351180
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
[TBL] [Abstract][Full Text] [Related]
17. Landscape and selection of vaccine epitopes in SARS-CoV-2.
Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A
Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050
[TBL] [Abstract][Full Text] [Related]
18. Immunoinformatics-Based Designing of a Multi-Epitope Chimeric Vaccine From Multi-Domain Outer Surface Antigens of
Kumar P; Lata S; Shankar UN; Akif M
Front Immunol; 2021; 12():735373. PubMed ID: 34917072
[TBL] [Abstract][Full Text] [Related]
19. In silico construction of a multiepitope Zika virus vaccine using immunoinformatics tools.
Antonelli ACB; Almeida VP; de Castro FOF; Silva JM; Pfrimer IAH; Cunha-Neto E; Maranhão AQ; Brígido MM; Resende RO; Bocca AL; Fonseca SG
Sci Rep; 2022 Jan; 12(1):53. PubMed ID: 34997041
[TBL] [Abstract][Full Text] [Related]
20. In Silico-Guided Sequence Modification of Epitopes in Cancer Vaccine Development.
Hoo WPY; Siak PY; In LLA
Methods Mol Biol; 2020; 2131():213-228. PubMed ID: 32162256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
